Epidemiological study of non-contagious intramammary infections in nine commercial dairy herds following a Staphylococcus aureus control programme

Changes in prevalence in intramammary infection, by pathogen type, in herds applying a stringent contagious mastitis control programme was studied. Enrollment of 1651 lactating cows and collection of milk samples was made in this ancillary study to a cohort study of the dynamics of mastitis prevalence after adoption of a strict contagious mastitis control programme that targeted the elimination of mastitis caused by Staphylococcus aureus. Nine commercial dairies in Italy were used. Aseptic collection of milk samples from all lactating cows was performed at the time of enrollment, from all cows within 7-14 days of entering the lactating herd after the date of enrollment, and from all lactating cows at 2, 4, 7, 10 and 14 months after the date of enrollment. Prevalence of intramammary infection by pathogen type was determined from culture of milk samples. Application of the strict contagious mastitis programme did not lead to an increased risk of non-contagious mastitis. The risk of coliform, environmental streptococcal and coagulase-negative staphylococcal intramammary infections decreased after adoption of the programme. The data reported herein indicate that the overall risk for any intramammary infections decreases with adoption of a strict contagious mastitis programme, and that such a programme therefore does not necessarily lead to an increase in environmental mastitis.     

Epidemiological Study of Non‐contagious Intramammary Infections in Nine Commercial Dairy Herds following a Staphylococcus aureus Control Programme

Changes in prevalence in intramammary infection, by pathogen type, in herds applying a stringent contagious mastitis control programme was studied. Enrollment of 1651 lactating cows and collection of milk samples was made in this ancillary study to a cohort study of the dynamics of mastitis prevalence after adoption of a strict contagious mastitis control programme that targeted the elimination of mastitis caused by Staphylococcus aureus. Nine commercial dairies in Italy were used. Aseptic collection of milk samples from all lactating cows was performed at the time of enrollment, from all cows within 7–14 days of entering the lactating herd after the date of enrollment, and from all lactating cows at 2, 4, 7, 10 and 14 months after the date of enrollment. Prevalence of intramammary infection by pathogen type was determined from culture of milk samples. Application of the strict contagious mastitis programme did not lead to an increased risk of non‐contagious mastitis. The risk of coliform, environmental streptococcal and coagulase‐negative staphylococcal intramammary infections decreased after adoption of the programme. The data reported herein indicate that the overall risk for any intramammary infections decreases with adoption of a strict contagious mastitis programme, and that such a programme therefore does not necessarily lead to an increase in environmental mastitis.     

Experimental intramammary infection of the dairy cow with Escherichia coli during the nonlactating period

The nonlactating mammary gland was experimentally inoculated with Escherichia coli. During the first half of the nonlactating period, 32% of 34 inoculated glands were temporarily infected. All intramammary infections were eradicated by the cow without therapy and no signs of mastitis were observed. During the 30 days before parturition occurred, 88% of 42 inoculated glands in the cows became infected. Twenty-three intramammary infections were eradicated by the cow and infection in 14 glands persisted after parturition occurred. Peracute toxic mastitis occurred in those cows with infected glands.     

Management strategies to decrease the prevalence of mastitis caused by one strain of Staphylococcus aureus in a dairy herd

The dairy herd at Washington State University had an outbreak of mastitis caused by a single strain of Staphylococcus aureus. The outbreak strain, termed novel, could not be controlled with routine contagious mastitis pathogen control procedures (incidence, 3.4 infections/100 cow months; peak prevalence > 22%). Our objective was to implement mastitis control measures that would decrease the incidence and prevalence of intramammary infection (IMI) caused by S aureus in the herd. The following intervention strategies were successfully implemented: strict segregation of cattle with IMI caused by S aureus, intensified culling of cattle with multiple-quarter IMI caused by S aureus, and inducing cessation of lactation of infected quarters in single-mammary-quarter infected cattle. One year after implementation of these control measures, incidence of IMI caused by S aureus was 0.35 infections/100 cow months, and prevalence had decreased from 20 to 8%.     

Coagulase-positive staphylococcal mastitis in a herd with low somatic cell counts

An increase in clinical mastitis infections was observed in a high-producing 77-cow Holstein herd. Low bulk tank somatic cell counts and individual cow Dairy Herd Improvement Association somatic cell counts observed before, during, and after the epizootic were suggestive of herd environmental mastitis. However, bacteriologic culture survey of the total herd indicated that, in addition to infections possibly attributable to environmental pathogens, 22% (17/77) of the cows were infected with coagulase-positive Staphylococcus spp. Conceivably, investigative efforts and management changes, without bacteriologic culturing, might have resulted in reduction of the clinical infection rate in this herd. However, the continued high prevalence of a contagious pathogen with potential future implications would have gone unnoticed. Somatic cell count in milk from individual cows generally is a useful tool for monitoring the probability of intramammary infection, but must be complemented with bacteriologic culture of milk to determine whether contagious or environmental pathogens are responsible.     

奶牛临床型乳房炎大肠杆菌的分离与鉴定

奶牛乳房炎是奶牛养殖业常见的一种临床疾病,该病是由大肠杆菌、链球菌、葡萄球菌等病原微生物引起的奶牛乳房发炎。该病的发生常常给奶牛养殖业带来极大的损失。本试验采集南京某奶牛场临床型乳房炎患牛的乳汁,并分离到3株细菌,经过对这3株细菌进行分离培养、形态染色、生化试验、药敏试验、致病性试验和血清型鉴定,结果表明这3株细菌均为O2血清型大肠杆菌,为临床预防和治疗提供了依据。     

A clinical trial to evaluate the effectiveness of antibiotic treatment of lactating cows with high somatic cell counts in their milk

OBJECTIVE: To determine the effectiveness of treatment of lactating cows with high somatic cell counts in milk. DESIGN: Randomised clinical trial. METHODS: Single pooled quarter samples of milk were obtained from cows with somatic cell counts above 500,000 cells/mL on fifty farms. Milk samples were cultured for known mastitis bacterial pathogens. Cows were randomly allocated to treated and untreated groups. Treated cows received both intramammary cloxacillin and parenteral erythromycin. Single pooled quarter milk samples were obtained at 6 weeks after treatment and were cultured for the presence of pathogenic bacteria. The percentage of samples with no growth at the post-treatment culture was used as an estimate of the bacteriological cures for each pathogen type and for each treatment group. Somatic cell counts of cows were compared between treatment groups and within pathogen group. The number of cows that completed a full lactation were compared between each treatment group and within each pathogen group. RESULTS: Treatment had no effect upon bacteriological cures, irrespective of pathogen present or the presence of bacteria during the previous lactation. There was no effect of treatment upon somatic cell count except for cows infected with Streptococcus dysgalactiae in which treatment caused a significant lowering of cell counts. This effect was not present in the subsequent lactation. Treatment of chronically infected cows did not alter the probability of a cow completing a full lactation but did improve the probability of newly infected cows being retained for the next lactation. Twenty-eight of 214 treated cows developed clinical mastitis in more than one quarter after treatment, thus indicating a poor technique by farmers for the insertion of intramammary antibiotics. CONCLUSIONS: Treatment during lactation of cows with high somatic cell counts in milk is ineffective in reducing bacterial infections and in reducing somatic cell counts to acceptable numbers.     

Severity of E. coli mastitis is mainly determined by cow factors

Intramammary infections of dairy cows with Gram-positive bacteria such as Staphylococcus aureus (major cause of mastitis) have received a lot of attention because of their major economic impact on the dairy farm through production losses induced by an increase in somatic cell count. Management strategies, including greater awareness for efficient milking and hygienic measures, have limited the spread of Gram-positive bacteria and resulted in a significant decrease of proportion of S. aureus isolates and subclinical mastitis worldwide. Other organisms such as coliform subspecies and Streptococcus uberis, both environmental bacteria that cause clinical mastitis, have received less attention. Escherichia coli causes inflammation of the mammary gland in dairy cows around parturition and during early lactation with striking local and sometimes severe systemic clinical symptoms. This disease affects many high producing cows in dairy herds and may cause several cases of death per year in the most severe cases. It is well known that bacterial, cow and environmental factors are interdependent and influence mastitis susceptibility. Many studies, executed during the last decade, indicate that the severity of E. coli mastitis is mainly determined by cow factors rather than by E. coli pathogenicity. During E. coli mastitis, the host defense status is a cardinal factor determining the outcome of the disease. Today, we know that the neutrophil is a key factor in the cows' defense against intramammary infection with E. coli. Effective elimination of the pathogen by neutrophils is important for the resolution of infection and the outcome of E. coli mastitis. This review is a compilation of some major findings over the last 15 years concerning mainly host factors that modulate and influence neutrophil function and the mammary inflammatory reaction. The individual chapters address: virulence factors of E. coli strains, how neutrophils kill E. coli, connection between endotoxins, tumor necrosis factor-alpha and nitric oxide, severity classification of E. coli mastitis, lifespan of neutrophils, host factors that influence severity, tissue damage and production loss.     

Clinical and bacteriological response to treatment of clinical mastitis with one of three intramammary antibiotics

AIM: To compare the proportions of clinical and bacteriological cure of glands of dairy cows diagnosed with clinical mastitis, following treatment with one of three different intramammary antibiotic preparations. METHODS: Cows from dairy cow herds (n=28) across New Zealand which were diagnosed with clinical mastitis in one or more glands at any stage of lactation were randomly assigned at the cow level within sequentially presented groups of three animals to be treated with one of three intramammary antibiotics. The treatments were 1 g procaine penicillin, 0.25 g cefuroxime, and a combination of 1 g procaine penicillin and 0.5 g dihydrostreptomycin (DHS). All treatments were infused on three occasions at 12-hourly intervals. Duplicate milk samples were collected for bacteriology before initial treatment, and 21-42 days later. Logistic regression or generalised linear mixed models were used to analyse the proportion of cows or quarters retreated for mastitis within 30 days of initial treatment ('clinical treatment failure'), and the proportion of glands from which bacteria were isolated initially but from which the same bacterial species was not re-isolated ('bacteriological cure'). RESULTS: The annual herd average cumulative incidence rate of clinical mastitis was 12.7 cases/100 cows. The incidence rate was higher in young (2-year-old) and old (> or = 9-year-old) cows relative to 3- and 4-year-old cows, and was higher in Friesian than Jersey or crossbred cows. Streptococcus uberis was the pathogen most commonly isolated, and its relative prevalence declined with time postpartum. Cows treated with cefuroxime were more likely (p<0.01) to be re-treated for clinical mastitis in the 30 days after initial treatment than cows treated with procaine penicillin or procaine penicillin and DHS. Bacteriological cure occurred in 74% of treated glands and there was no difference in the proportion of cures among the treatments (p=0.4). The proportion of cures was lower when treatment occurred 28-72 days after calving (p<0.01) and if a major pathogen was isolated (p<0.001). CONCLUSIONS AND CLINICAL RELEVANCE: There was no benefit in terms of clinical or bacteriological cure rate in treating clinical mastitis cases with the combination of procaine penicillin and DHS compared to treatment with procaine penicillin alone. The proportion of clinical mastitis cases re-treated differed among herds, and more cows treated with cefuroxime were retreated within 30 days of initial treatment. However, the bacteriological cure proportion was the same among the treatments. Cure proportions were lower in cows from which major mastitis pathogens were isolated and when treatment commenced 28-72 days after calving.     

奶牛乳房炎主要病原菌感染流行规律研究进展

乳房炎作为全球性奶牛养殖业的重要疾病,因对社会经济、养殖行业和人类健康的巨大影响使人们从发病机理、疾病诊断、预防等方面对其进行了不断的研究与探讨。作者立足于前期尤其是近几年的研究文献,以引起奶牛乳房炎的重要原因——病原菌为中心展开,探讨其感染类型、奶牛与病原菌及病原菌相互之间的关系。奶牛乳房炎是由包括病原菌的侵袭及宿主奶牛自身抵抗力等多种因素共同作用导致,乳腺对病原菌的入侵应答能力,病原与病原之间或促进或抑制都对其发生产生影响。金黄色葡萄球菌是公认的奶牛乳房炎的主要传染性病原菌,其独特的生物学特性使得其在体内难以治疗,并且耐药性普遍存在;无乳链球菌是环境性还是传染性病原尚有争议,在中国感染率较高,对大部分抗生素仍旧敏感,相对于其他病原菌治愈率较高,畜群清除容易;大肠埃希氏菌被作为环境性病原体,乳房炎感染的分离率仍较高,抗生素治疗结果还有待商榷,耐药性普遍存在并增强;牛支原体近十年的感染率有所上升,在国内外都是严重的乳房炎致病因素,治疗效果不佳,且耐药性正在增强,疫苗开发困难。文章对上述几种主要病原菌的流行、危害与防治等研究进行综述,以期为奶牛生产管理和科学研究方面提供参考。     

Mastitis prevalence and the selection of dry cow therapy programmes in dairy herds

Sales of intramammary cerates to a group of 142 dairy farms over a period of two years were monitored. On the assumption that three tubes of cerate are used to treat one case of mastitis, an estimate was made of the prevalence of clinical mastitis in these herds. The prevalence in seasonal supply herds was 21 cases per 100 cows per year and the prevalence in town supply herds was 66 cases per 100 cows per year. The usage of dry cow therapy was related to changes in the prevalence of clinical mastitis in these herds. The use of whole-herd therapy reduced the prevalence of clinical mastitis in herds which had a high prevalence in the first year, but in herds with a low prevalence of clinical mastitis the prevalence increased after the use of dry cow therapy.     

Prevalence of bovine subclinical mastitis and antibiotic susceptibility patterns of major mastitis pathogens isolated in Unguja island of Zanzibar,Tanzania

A cross-sectional study was conducted between January and July 2014 in Unguja island of Zanzibar to establish prevalence of subclinical mastitis (SCM) in smallholder dairy cows and patterns of antibacterial susceptibility of major mastitis pathogens isolated. A total of 416 dairy cows from 201 farmers were randomly selected from three districts of Unguja Island to participate in the study. Questionnaire interview, field observation, individual cow examination, California Mastitis Test (CMT) and bacteriological examination were carried out. Kirby-Bauer disc diffusion technique was used to test drug sensitivity for common bacteria isolated. Based on CMT results, the overall prevalence of SCM was 28.6, 48.8 and 64.7% at quarter, cow and farm level, respectively. Prevalence of bacterial infection was recorded at 42.9, 70.9 and 78.6% at quarter, cow and farm examined, respectively. The common bacteria isolated included Staphylococcus aureus (36.8%), Pseudomonas aeruginosa (17.8%), Staphylococcus epidermidis (16.1%), Klebsiella spp. (9.5%), Micrococcus spp. (6.3%) and Escherichia coli (4.9%). In conclusion, findings of this study demonstrated high level of subclinical mastitis at farms, cows and quarters levels with both contagious and environmental bacterial pathogen involved. Therefore, efforts should be directed to the decreased subclinical mastitis by improving sanitary measures and proper milking practice.     

辽西地区规模化奶牛场奶牛乳房炎发病情况监测

[目的]为了摸清辽西地区规模化奶牛场奶牛隐性乳房炎发病情况,[方法]本研究应用美国加州奶牛乳房炎检测方法(California mastitis test,CMT)对规模化奶牛场奶牛定期采集奶样进行隐性乳房炎动态监测.通过临床检查和CMT方法对辽西地区5个规模化奶牛养殖场共1 326头泌乳期奶牛进行了隐性乳房炎的监测,...     

新疆郊区奶牛健康养殖状况调查

[目的]以新疆天山北坡昌吉市郊区散养和规模化奶牛养殖场为对象,对奶牛体况、环境压力、牛体污染、乳房炎、血液性状等健康指标进行了调查分析。[方法]选择奶牛散养户5户和规模化奶牛养殖场的干奶期、泌乳初期和泌乳中期奶牛,分别于冬季和夏季进行体况、环境压力、乳房炎、血液性状等健康指标的测定与分析。[结果]干奶牛体况值略低于奶牛体况评分的理想值（3．5）;奶牛呼吸数夏季增加,超过50次／min;规模化奶牛养殖场的污染程度比散养户要高,尤其是冬季50％以上奶牛的牛体污染评价值高于3。规模化奶牛养殖场的奶牛乳房炎发病率达40％,并发现了感染金黄色葡萄球菌的病例。低血糖奶牛占一半以上．特别是干奶期比较突出。血液Alb和BUN偏低,干奶期牛群的BUN大多低于7mg／dL。血液中谷草转氨酶（AST）偏高,谷氨酰转肽酶（GGT）偏低,Ca含量正常,Mg含量较低。[结论]规模化奶牛养殖场存在干奶期奶牛能量及蛋白质不足;冬季环境恶劣并且污染程度较重,牛体污染及乳房炎发病率高;飞节损伤引起的肝功能衰退等现象,需要改进。     

Quarter,cow, and farm risk factors for intramammary infections with major pathogens relative to minor pathogens in Thai dairy cows

A cross-sectional study was carried out from May to September 2011 on 35 smallholder dairy farms in Chiang Mai, Thailand, to identify the quarter, cow, and farm factors that relate to intramammary infections (IMI) from major specified pathogens, compared to infections from minor pathogens. Data on general farm management, milking management, and dry cow management were recorded for each herd. Quarter milk samples were collected from either clinical or subclinical mastitis quarters. Dependent variables were binary data defining the specified major pathogens, including Streptococcus agalactiae (7.1 %), Streptococcus uberis (9.4 %), Streptococcus dysgalactiae (4.0 %), and other streptococci (16.7 %), as a case, and all minor pathogens as a control, in each dependent variable. The occurrence of S. agalactiae IMI was lower in first-parity cows and cows with short milking time. Cows with body condition score (BCS) <2.5 had higher occurrence of S. agalactiae IMI. The occurrence of S. uberis IMI was higher in quarters with California mastitis test (CMT) score 2, score 3, and having clinical mastitis and in farms with increasing age of vacuum system. Quarters with CMT score 3, having clinical mastitis, cow with manual milking after detaching milking cluster, and farms with high bulk milk somatic cell counts (BMSCC >500,000 cells/ml) had higher occurrence of S. dysgalactiae IMI. For other streptococci, quarters having clinical mastitis, BCS <2.5, and pulling down of milking cluster while milking increased occurrence of other streptococci IMI relative to minor pathogen IMI. These results highlight the importance of individual cow factors, milking characteristics, and BMSCC in determining the risk of IMI from major pathogens.     

Prevalence of subclinical mastitis and associated risk factors in smallholder dairy cows in Tanzania

A cross-sectional study was carried out on 200 randomly selected farms in each of the Iringa and Tanga regions of Tanzania to estimate the prevalence and risk factors for subclinical mastitis in dairy cows kept by smallholders. Subclinical mastitis was assessed using the California mastitis test (cmt), and by the bacteriological culture of 1500 milk samples collected from 434 clinically normal cows. The percentages of the cows (and quarters) with subclinical mastitis were 75.9 per cent (46.2 per cent) when assessed by the cmt and 43.8 per cent (24.3 per cent) when assessed by culture. Factors significantly associated with an increased risk of a cmt-positive quarter were Boran breed (odds radio [or]=3.51), a brought-in cow (rather than homebred) (or=2.39), peak milk yield, and age. The stripping method of hand milking was associated with a significantly lower prevalence of cmt-positive quarters (or=0.51). The cmt-positive cows were more likely to be culture positive (or=4.51), as were brought-in (or=2.10) and older cows.     

基于DHI平台开展奶牛乳房炎诊断及治疗效果的研究

为评估DHI中的体细胞值对奶牛乳房炎的预警作用,以湖南省DHI中心对宁乡某规模化奶牛场2019年3-4月份DHI数据为基础,结合乳房炎快速检测液,筛选临床或隐性乳房炎奶牛,确定为药物治疗效果试验组。采集筛选牛群奶样,进行细菌分离培养、鉴定,结合药敏实验开展针对性治疗,观察治疗效果。结果发现:从试验组奶样中均分离出各种乳房炎致病菌,其中主要是大肠杆菌和金黄色葡萄球菌;经敏感药物治疗后,患牛乳中体细胞数(SCC)下降极显著(P<0.01)。结论:体细胞数(SCC)作为DHI检测的一项重要指标,对奶牛乳房炎起到第一预警作用;DHI报告同时针对出现的问题提出相应的改进措施,以期使DHI成为牛场发现管理问题、增加养殖效益的有效工具,切实服务于奶牛场的实际生产。     

Clinical mastitis in dairy cattle in Ontario: frequency of occurrence and bacteriological isolates.

The objective of this study was to describe the frequency of occurrence of clinical mastitis in dairy herds in Ontario. The study group consisted of 65 dairy farms involved in a 2-year observational study, which included recording all clinical mastitis cases and milk sampling of quarters with clinical mastitis. Lactational incidence risks of 9.8% for abnormal milk only, 8.2% for abnormal milk with a hard or swollen udder, and 4.4% for abnormal milk plus systemic signs of illness related to mastitis were calculated for 2840 cows and heifers. Overall, 19.8% of cows experienced one or more cases of clinical mastitis during location. Teat injuries occurred in 2.1% of lactations. Standard bacteriology was performed on pretreatment milk samples from 834 cows with clinical mastitis. The bacteria isolated were Staphylococcus aureus (6.7%), Streptococcus agalactiae (0.7%), other Streptococcus spp. (14.1%), coliforms (17.2%), gram-positive bacilli (5.5%), Corynebacterium bovis (1.7%), and other Staphylococcus spp. (28.7%). There was no growth in 17.7% of samples, and 8.3% of samples were contaminated. Clinical mastitis is a common disease in dairy cows in Ontario; approximately 1 in 5 cow lactations have at lease one episode of clinical mastitis. There is, however, considerable variation in the incidence of clinical mastitis among farms. The majority of 1st cases of clinical mastitis occur early in lactation, and the risk of clinical mastitis increases with increasing parity. Environmental, contagious, and minor pathogens were all associated with cases of clinical mastitis.     

河北保定部分奶牛场临床型乳房炎发病情况调查研究

为探索奶牛临床型乳房炎的发病情况与泌乳量、泌乳期、季节之间的联系,以河北保定地区5个奶牛场为例进行调查研究。通过对调查结果的统计分析,结果显示：奶牛乳房炎多发生在泌乳90~150 d,泌乳天数越长发病头数越多;从产奶量来看,泌乳量越高发病牛比例越高;从发病季节来看,奶牛乳房炎在秋季发病率高,春季、夏季和冬季发病率低。     

Assessment of antimicrobial transfer from treated to untreated mammary gland quarters by use of high-pressure liquid chromatography for detection of cloxacillin in milk samples from nonlactating dairy cows

OBJECTIVE: To determine whether half-udder intramammary infusion of cloxacillin results in transfer of cloxacillin from treated to untreated mammary gland quarters within nonlactating cows, and, if so, at what concentrations, and to determine whether selection of ipsilateral versus diagonal-contralateral quarters for treatment affects cloxacillin transfer among quarters. ANIMALS: 20 Holstein-Friesian cows from a dairy herd. PROCEDURES: A within-cow half-udder comparison trial was used in which 2 of 4 mammary gland quarters (ipsilaterally or diagonally) received an intramammary infusion of cloxacillin on day 1 of the nonlactating period. Three days later, milk samples were taken from all untreated quarters and high-pressure liquid chromatography was used to detect and quantify milk cloxacillin concentrations. RESULTS: Cloxacillin was detected in 25% of all untreated mammary gland quarters. Mean cloxacillin concentration in untreated quarters was below minimum inhibitory concentrations for targeted mastitis pathogens. No significant difference in cloxacillin concentrations was found in the ipsilateral or diagonal treatment groups. CONCLUSIONS AND CLINICAL RELEVANCE: Within-cow half-udder comparison trials are valid for antimicrobial trials in nonlactating cows, although transfer of antimicrobials does occur in trace concentrations. Ipsilateral or diagonal-contralateral treatment designs perform similarly. This type of design is economical for researchers, although care must be taken to account for within-cow clustering of mammary gland quarter data.